Expansion Technologies

Executive Summary

Expansion Technologies, founded in 2016 and headquartered in San Diego, CA, is pioneering a novel approach to neuroscience by combining expansion microscopy with advanced imaging to map the brain at nanoscale resolution. The company's proprietary platform enables large-scale, nanoprecise imaging of brain tissue, providing ground truth connectivity and molecular information. This data is used to create high-fidelity computer simulations of the human brain, with potential applications in understanding neurological diseases, drug discovery, and artificial intelligence. Expansion Technologies addresses a critical gap in neuroscience: the lack of comprehensive, circuit-level maps of the brain. By integrating molecular, structural, and connectomic data, the company aims to build the most accurate brain models ever created. While still in a relatively early stage, Expansion Technologies is positioned at the intersection of multiple high-growth fields, including expansion microscopy, connectomics, and computational neuroscience. The company's technology has been validated in academic settings, but commercial traction remains limited. The primary near-term catalysts include securing series A funding, publishing landmark studies demonstrating brain-map resolution, and forming strategic partnerships with pharmaceutical companies or research consortia. If successful, Expansion Technologies could become a key enabler for next-generation neuroscience, though execution risks remain high given the technical challenges and long development timelines typical of deep-tech biotech.

Upcoming Catalysts (preview)

• Q3 2026Series A funding round70% success
• Q4 2026Publication of first high-resolution brain map60% success
• Q2 2026Strategic partnership with neuroscience research center50% success